Craig-Hallum provides banking, research, institutional sales, and trading services. This description is self-described.

Craig-Hallum

Craig-Hallum Capital Group | 5,455 followers on LinkedIn. Employee-owned, idea-driven research, trading and investment banking firm.  | Since starting in 1997, we have kept our focus clear: help our clients achieve their goals. The success of our firm depends on our culture and our people. We believe we have some of the best at what they do and we’re committed to working hard and staying true to our business model.

Managing Director at Craig-Hallum Capital Group

Joseph Dews

George Sutton

Eric Stine

Chief Compliance Officer at Craig-Hallum Capital Group

Chris Jensen

Craig-Hallum Capital Group

Join us for Craig-Hallum’s first Nuclear Energy Revisited – Virtual Conference on Wednesday, December 11, 2024. Featuring 1x1 meetings with a range of public and private companies that participate in the nuclear supply chain from fuels to fission and fusion reactors. This conference will highlight key marketplace developments that are driving the nuclear renaissance as well as feature a “Nuclear Energy 101” Teach-in Fireside Chat with Eric Stine , Sr. Research Analyst. Please contact your Craig-Hallum representative to register.

Congratulations to our client Applied DNA Sciences, Inc. (APDN) on the success of its recent offering in October 2024 where Craig-Hallum served as sole placement agent. APDN is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (“DNA”) and ribonucleic acid (“RNA”).

Congratulations to our client Applied Digital Corp. (APLD) on the success of its recent offering in October 2024 where Craig-Hallum served as co-manager. APLD is a designer, developer, and operator of next-generation digital infrastructure across North America. They provide digital infrastructure solutions and cloud services to the rapidly growing industries of High-Performance Computing and Artificial Intelligence.

Congratulations to our Senior Research Analyst, Matt Hewitt, on hosting a successful turnout at the virtual Bioprocessing Conference held last week. The bioprocessing industry plays a crucial role in the development and commercialization of biologic drugs and cell and gene therapies. During the conference, our clients delved into how bioprocessing tools and services are driving innovation and transforming the pharmaceutical and biotechnology industries. With 10 companies hosting fireside chats and close to 90 1x1 meetings, our conferences continue to reflect our ongoing commitment to identify and introduce investment opportunities to our clients. Thank you to all our participants.

Congratulations to our client Orion Group Holdings, Inc. (ORN) on the success of its recent offering in September 2024 where Craig-Hallum served as sole book-running manager. ORN is a leading specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Hawaii, Canada and the Caribbean Basin through their marine segment and their concrete segment.

Congratulations to our client Zeta Global Holdings Corp. (ZETA) on the success of its recent offering in September 2024 where Craig-Hallum served as co-manager. Zeta is a leading omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software.

Congratulations to our client Phathom Pharmaceuticals, Inc. (PHAT) on the success of its recent offering in August 2024 where Craig-Hallum served as co-lead manager. PHAT is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.

Congratulations to our client Life Time Group Holdings, Inc. (LTH) on the success of its recent offering in August 2024 where Craig-Hallum served as co-manager. Life Time, the “Healthy Way of Life Company,” is a premier lifestyle and leisure brand offering premium health, fitness and wellness experiences to a community of more than 1.5 million individual members.

Congratulations to our client scPharmaceuticals Inc. (SCPH) on the success of its recent offering in August 2024 where Craig-Hallum served as co-manager. SCPH is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs.

Congratulations to our client Xtant Medical Holdings, Inc. (XTNT) on the success of its recent offering in August 2024 where Craig-Hallum served as sole placement agent. XTNT is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures.

CRAI

COM:CRAIG-HALLUM

Craig-Hallum